Article Details

Tezepelumab as an Emerging Biologic to Treat Asthma

Retrieved on: 2021-07-18 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Tezepelumab as an Emerging Biologic to Treat Asthma. View article details on hiswai:

Excerpt

Tezepelumab is an injectable subcutaneous monoclonal antibody that's given for patients with severe asthma, in the hope that it blocks T2 inflammation.

Article found on: www.hcplive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up